| Primary |
| Product Used For Unknown Indication |
43.8% |
| Drug Use For Unknown Indication |
25.0% |
| Pain |
6.6% |
| Back Pain |
3.4% |
| Erysipelas |
1.9% |
| Insomnia |
1.8% |
| Intentional Overdose |
1.8% |
| Arthralgia |
1.6% |
| Post-traumatic Pain |
1.6% |
| Prophylaxis |
1.6% |
| Anxiety |
1.5% |
| Skin Infection |
1.5% |
| Anaesthesia |
1.2% |
| Neck Pain |
1.2% |
| Abdominal Pain |
1.0% |
| Breast Cancer |
1.0% |
| Musculoskeletal Pain |
1.0% |
| Osteoarthritis |
1.0% |
| Agitation |
0.9% |
| Hiv Infection |
0.9% |
|
| Vomiting |
18.4% |
| International Normalised Ratio Increased |
11.8% |
| Withdrawal Syndrome |
9.2% |
| Neutropenia |
6.6% |
| Cytolytic Hepatitis |
5.3% |
| Somnolence |
5.3% |
| Hepatocellular Injury |
3.9% |
| Hyponatraemia |
3.9% |
| Multiple Drug Overdose Intentional |
3.9% |
| Thrombocytopenia |
3.9% |
| Urinary Retention |
3.9% |
| Acute Generalised Exanthematous Pustulosis |
2.6% |
| Agranulocytosis |
2.6% |
| Confusional State |
2.6% |
| Drug Interaction |
2.6% |
| Fall |
2.6% |
| Hypoglycaemia |
2.6% |
| Inappropriate Antidiuretic Hormone Secretion |
2.6% |
| Infertility Male |
2.6% |
| Insomnia |
2.6% |
|
| Secondary |
| Drug Use For Unknown Indication |
28.4% |
| Product Used For Unknown Indication |
24.7% |
| Pain |
11.6% |
| Hypertension |
6.8% |
| Back Pain |
4.9% |
| Arthralgia |
2.7% |
| Depression |
2.4% |
| Neuralgia |
2.3% |
| Headache |
2.2% |
| Anxiety |
2.1% |
| Erysipelas |
1.6% |
| Prophylaxis |
1.5% |
| Thrombosis Prophylaxis |
1.5% |
| Insomnia |
1.1% |
| Rheumatoid Arthritis |
1.1% |
| Type 2 Diabetes Mellitus |
1.1% |
| Arthritis |
1.0% |
| Extragonadal Primary Germ Cell Tumour Mixed Stage I |
1.0% |
| Nausea |
1.0% |
| Atrial Fibrillation |
0.9% |
|
| Toxic Epidermal Necrolysis |
16.8% |
| Rash Maculo-papular |
8.0% |
| Malaise |
7.1% |
| Epilepsy |
6.2% |
| Withdrawal Syndrome |
6.2% |
| Fall |
5.3% |
| Hepatocellular Injury |
4.4% |
| Pancreatitis Acute |
4.4% |
| Vomiting |
4.4% |
| Cytolytic Hepatitis |
3.5% |
| Hyponatraemia |
3.5% |
| Malnutrition |
3.5% |
| Muscle Haemorrhage |
3.5% |
| Neutropenia |
3.5% |
| Renal Failure Acute |
3.5% |
| Somnolence |
3.5% |
| Sudden Death |
3.5% |
| Urinary Retention |
3.5% |
| Acute Generalised Exanthematous Pustulosis |
2.7% |
| Convulsion |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
21.8% |
| Product Used For Unknown Indication |
15.7% |
| Pain |
12.0% |
| Hypertension |
7.6% |
| Rheumatoid Arthritis |
6.0% |
| Prophylaxis |
4.1% |
| Hiv Infection |
3.6% |
| Thrombosis Prophylaxis |
3.2% |
| Back Pain |
3.1% |
| Anxiety |
2.8% |
| Crohn's Disease |
2.7% |
| Osteoporosis |
2.5% |
| Ankylosing Spondylitis |
2.2% |
| Constipation |
2.2% |
| Depression |
2.2% |
| Nausea |
2.1% |
| Abdominal Pain |
1.7% |
| Diffuse Large B-cell Lymphoma |
1.6% |
| Breast Cancer |
1.5% |
| Infection |
1.5% |
|
| Renal Failure Acute |
9.3% |
| Thrombocytopenia |
9.3% |
| Toxic Skin Eruption |
9.3% |
| Vomiting |
7.7% |
| Weight Decreased |
7.2% |
| Pyrexia |
6.2% |
| Cytolytic Hepatitis |
5.2% |
| Neutropenia |
5.2% |
| Renal Failure |
4.6% |
| General Physical Health Deterioration |
4.1% |
| Pulmonary Embolism |
4.1% |
| Agranulocytosis |
3.6% |
| Tachycardia |
3.6% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.1% |
| Pancreatitis Acute |
3.1% |
| Transient Ischaemic Attack |
3.1% |
| Vertigo |
3.1% |
| Weight Increased |
3.1% |
| Drug Ineffective |
2.6% |
| Rash |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
32.3% |
| Depression |
9.7% |
| Drug Use For Unknown Indication |
9.7% |
| Headache |
9.7% |
| Pain |
9.7% |
| Parkinson's Disease |
6.5% |
| Epilepsy |
3.2% |
| Gastric Neoplasm |
3.2% |
| Hepatic Neoplasm Malignant |
3.2% |
| Hypersensitivity |
3.2% |
| Pain Prophylaxis |
3.2% |
| Prophylaxis |
3.2% |
| Rhinitis Allergic |
3.2% |
|
| Overdose |
28.6% |
| Hallucination |
14.3% |
| Hypoxia |
14.3% |
| Malnutrition |
14.3% |
| Thrombocytopenia |
14.3% |
| Toxicity To Various Agents |
14.3% |
|
